Literature DB >> 26214202

Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.

Yucheng Wang1, Chengbin Yang, Rui Hu, Hui Ting Toh, Xin Liu, Guimiao Lin, Feng Yin, Ho Sup Yoon, Ken-Tye Yong.   

Abstract

In this work, we demonstrate the use of manganese doped zinc selenide QDs (Mn:ZnSe d-dots) for gene delivery in vitro. Specifically, the d-dots were prepared as nanoplexes for facilitating the intracellular delivery of small interfering RNA (siRNA) molecules to pancreatic cancer cells (Panc-1), thereby inducing sequence-specific silencing of oncogenic K-Ras mutations in pancreatic carcinoma. For nanoplex preparation, a layer-by-layer (LBL) assembling method was adopted to modify the d-dot surface with cationic polymer poly(allylamine hydrochloride) (PAH) or polyethylenimine (PEI) for generating positive surface potential for complexing with K-Ras siRNA molecules. Owing to the unique and stable PL properties of the d-dots, siRNA transfection and the subsequent intracellular release profile from the d-dot/polymer-siRNA nanoplexes were monitored by fluorescence imaging. Quantitative results from flow cytometry study suggested that a high gene transfection efficiency was achieved. The expression of the mutant K-Ras mRNA in Panc-1 cells was observed to be significantly suppressed upon transfecting them with the nanoplex formulation. More importantly, cell viability studies showed that the d-dot/PAH nanoplexes were biocompatible and non-toxic even at concentrations as high as 160 μg mL(-1). Furthermore, the amine-terminated surface could be further modified to obtain multiple bio-functions. Based on these results, we envision that the designed d-dot nanoplexes can be developed as a flexible nanoplatform for both fundamental and practical clinical research applications.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26214202     DOI: 10.1039/c4bm00306c

Source DB:  PubMed          Journal:  Biomater Sci        ISSN: 2047-4830            Impact factor:   6.843


  6 in total

Review 1.  Current Transport Systems and Clinical Applications for Small Interfering RNA (siRNA) Drugs.

Authors:  Fang Liu; Chunfang Wang; Yuantao Gao; Xiao Li; Feng Tian; Yongtao Zhang; Mingyang Fu; Pengfei Li; Yali Wang; Fei Wang
Journal:  Mol Diagn Ther       Date:  2018-10       Impact factor: 4.074

2.  Quantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells.

Authors:  Guimiao Lin; Ting Chen; Jinyun Zou; Yucheng Wang; Xiaomei Wang; Jiefeng Li; Qijun Huang; Zicai Fu; Yingying Zhao; Marie Chia-Mi Lin; Gaixia Xu; Ken-Tye Yong
Journal:  Front Pharmacol       Date:  2017-04-04       Impact factor: 5.810

3.  Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.

Authors:  Yu Xia; Tiantian Xu; Changbing Wang; Yinghua Li; Zhengfang Lin; Mingqi Zhao; Bing Zhu
Journal:  Int J Nanomedicine       Date:  2017-12-22

4.  Hydrogen Peroxide and Hypochlorite Responsive Fluorescent Nanoprobes for Sensitive Cancer Cell Imaging.

Authors:  Yun Chen; Jing Ye; Gang Lv; Weiwei Liu; Hui Jiang; Xiaohui Liu; Xuemei Wang
Journal:  Biosensors (Basel)       Date:  2022-02-11

Review 5.  The Research and Applications of Quantum Dots as Nano-Carriers for Targeted Drug Delivery and Cancer Therapy.

Authors:  Mei-Xia Zhao; Bing-Jie Zhu
Journal:  Nanoscale Res Lett       Date:  2016-04-18       Impact factor: 4.703

Review 6.  Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Authors:  Sepideh Mirzaei; Mohammad Hossein Gholami; Hui Li Ang; Farid Hashemi; Ali Zarrabi; Amirhossein Zabolian; Kiavash Hushmandi; Masoud Delfi; Haroon Khan; Milad Ashrafizadeh; Gautam Sethi; Alan Prem Kumar
Journal:  Cells       Date:  2021-11-29       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.